Teva Pharmaceutical Industries (TEVA) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 49.5%
EBITDA Margin: 22.4%
Op. Margin: 16.4%
Net Margin: 9.3%

Op. margin of 16.4% is up 3.0% YoY — cost efficiency is improving. Net margin at 9.3% and gross margin of 49.5% — earnings take a bigger bite when COGS stays lean..

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit